Allogeneic Stem Cell Transplantation for Patients Age >= 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT

Author(s):
Heidenreich, S.; Ziagkos, D.; Wreede, L.C. de (0000-0002-7667-9369); Biezen, A. van; Finke, J.; Platzbecker, U.; Niederwieser, D.; Einsele, H.; Bethge, W.; Schleuning, M.; Beelen, D.W.; Tischer, J.; Nagler, A.; Glass, B.; Maertens, J.; Yanez, L.; Beguin, Y.; Sill, H.; Scheid, C.; Stelljes, M.; Ganser, A.; Zachee, P.; Selleslag, D.; Witte, T. de; Robin, M.; Kroger, N.
Published
2017
Publication type
Article / Letter to editor
Myelodysplastic syndromeMDSAcute myeloid leukemiaAMLKarnofsky performance statusCMVHSCTEBMTAge
Date issued
2017-01-31
Language
English
Is part of
Biology of Blood and Marrow Transplantation (2017), Vol. 23, no. 1, p. 44-52
hdl
1887/116354
doi
10.1016/j.bbmt.2016.09.027